Advances in Molecular Pathology (AMP)

Advances in Molecular Pathology is an annual review journal published by Elsevier Inc. that consolidates the latest clinical and laboratory developments in the rapidly evolving field of molecular pathology. First issued in 2018, it publishes one comprehensive volume each year, featuring review articles authored by internationally recognized experts in subspecialties such as genetics, hematopathology, infectious disease, pharmacogenomics, informatics, and solid tumor diagnostics. With Print ISSN 2589-515X and Online E-ISSN 2589-4080, the publication provides a valuable resource for pathologists, clinical laboratory scientists, and related healthcare professionals seeking authoritative overviews that translate cutting-edge research into clinical insights and practical applications. Each issue is structured into thematic sections that highlight significant advances in molecular diagnostics and their impact on patient care, including topics such as emerging genomic technologies, biomarker discovery, bioinformatics tools, and applications of next-generation sequencing. Editorial leadership currently includes Ahmad Abou Tayoun, PhD, FACMG, with previous contributions overseen by Gregory J. Tsongalis, PhD, HCLD, CC, FNACB. As a review publication with an invited international editorial board, Advances in Molecular Pathology helps clinicians and laboratorians stay informed of key trends and breakthroughs in molecular pathology practice, enhancing diagnostic accuracy and patient outcomes.

Advances in Molecular Pathology (AMP) is :-

• International, Peer-Reviewed, Open Access, Refereed, Molecular Biology, genomic sequencing, molecular mechanisms of disease, integration of new technologies, biomarkers for cancer and infectious diseases , Online or Print , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2589-515X, E-ISSN: 2589-4080, Established: 2018,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE